News Psychedelics and mental health: The time is now? Following news this week of Australia becoming the first country to legalise the prescription of the psychedelics MDMA for PTSD and
Patients Partner Content Understanding Rare Conditions: The Compounding Impact, Inter... More than half of NMOSD In America 2022 respondents said being diagnosed with NMOSD has negatively impacted their mental health.
R&D One size does not fit all: Why a shift is needed in how we t... Two of the biggest advances in healthcare in the last decade have been the gradual de-stigmatisation of mental health and the increased interest in researching the causes and treatments of
News UK funds extended reality projects for mental health Innovate UK has funded three projects in its Mindset programme, which aims to support the development of extended and
Home Considering a new standard of care in schizophrenia As a psychiatrist, I have observed that schizophrenia is a widely known, but poorly understood mental health condition.
News NHSBSA releases latest Medicines Used in Mental Health data Covering October to December 2022, the report recorded 21.7m antidepressant items prescribed.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
